A role, or even an exclusive role, for GOLPH3 in retaining enzymes in the Golgi would certainly not be incompatible with these findings, as there is extensive evidence that changes in glycosylation are a hallmark of cancer cells, and they have been linked to increased tumor growth and invasiveness (Stowell et al., 2015). The gene discussed is GOLPH3; the disease is neoplasm.